WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Repligen Corp. (RGEN) on Tuesday reported third-quarter net income of $18.2 million.
On a per-share basis, the Waltham, Massachusetts-based company said it had net income of 32 cents. Earnings, adjusted for one-time gains and costs, were 23 cents per share.
The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 14 cents per share.
The drug developer posted revenue of $141.2 million in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $138.4 million.
Repligen expects full-year earnings in the range of $1.70 to $1.76 per share, with revenue in the range of $635 million to $645 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGEN at https://www.zacks.com/ap/RGEN